BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $129B
1-Year Return 16.6%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Quarter Return
+2.51%
1 Year Return
+16.6%
3 Year Return
+55.5%
5 Year Return
+79.05%
10 Year Return
+178.41%
AUM
$129B
AUM Growth
+$26.5B
Cap. Flow
+$24.2B
Cap. Flow %
18.75%
Top 10 Hldgs %
22.4%
Holding
4,694
New
1,253
Increased
1,352
Reduced
1,621
Closed
134

Sector Composition

1 Technology 26.74%
2 Consumer Discretionary 11.23%
3 Financials 10.63%
4 Healthcare 8.41%
5 Communication Services 8.06%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
INVE icon
4151
Identive
INVE
$89.2M
$505 ﹤0.01%
138
JMUB icon
4152
JPMorgan Municipal ETF
JMUB
$3.57B
$502 ﹤0.01%
+10
New +$502
EFAV icon
4153
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.44B
$495 ﹤0.01%
+7
New +$495
IMDX
4154
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$85.9M
$495 ﹤0.01%
+208
New +$495
CVM icon
4155
CEL-SCI Corp
CVM
$66.6M
$491 ﹤0.01%
41
API
4156
Agora
API
$337M
$487 ﹤0.01%
+117
New +$487
CTXR icon
4157
Citius Pharmaceuticals
CTXR
$20.6M
$484 ﹤0.01%
121
+2
+2% +$8
VFH icon
4158
Vanguard Financials ETF
VFH
$12.8B
$472 ﹤0.01%
+4
New +$472
QVCGA
4159
QVC Group, Inc. Series A Common Stock
QVCGA
$83.7M
$466 ﹤0.01%
28
-10
-26% -$166
CDTX icon
4160
Cidara Therapeutics
CDTX
$1.61B
$457 ﹤0.01%
17
SGMO icon
4161
Sangamo Therapeutics
SGMO
$160M
$450 ﹤0.01%
441
-2,665
-86% -$2.72K
AREN icon
4162
Arena Group
AREN
$291M
$449 ﹤0.01%
+335
New +$449
KRON
4163
DELISTED
Kronos Bio
KRON
$447 ﹤0.01%
+471
New +$447
SNCR icon
4164
Synchronoss Technologies
SNCR
$62.8M
$432 ﹤0.01%
45
-884
-95% -$8.49K
ANTX icon
4165
AN2 Therapeutics
ANTX
$33.6M
$431 ﹤0.01%
+312
New +$431
AWH
4166
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$430 ﹤0.01%
+610
New +$430
LEE icon
4167
Lee Enterprises
LEE
$27.3M
$429 ﹤0.01%
+29
New +$429
AXDX
4168
DELISTED
Accelerate Diagnostics
AXDX
$428 ﹤0.01%
+357
New +$428
LSF icon
4169
Laird Superfood
LSF
$62.3M
$410 ﹤0.01%
+52
New +$410
IBDR icon
4170
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.35B
$409 ﹤0.01%
17
GREE icon
4171
Greenidge Generation Holdings
GREE
$21.6M
$408 ﹤0.01%
+263
New +$408
UBFO icon
4172
United Security Bancshares
UBFO
$166M
$394 ﹤0.01%
+39
New +$394
ECOR icon
4173
electroCore
ECOR
$37.2M
$389 ﹤0.01%
+24
New +$389
VIGL
4174
DELISTED
Vigil Neuroscience
VIGL
$388 ﹤0.01%
+228
New +$388
UONEK icon
4175
Urban One Class D
UONEK
$37.7M
$384 ﹤0.01%
386
+19
+5% +$19